I have no direct insight into the operations of the blood diagnostic company Theranos, and I’ve never met Elizabeth Holmes.
But something clearly went off the rails at Theranos.
The positioning of Holmes as “The Next Steve Jobs” and a $9 billion valuation certainly set her up for a nasty fall.
